2018-2023 Global Companion Diagnostic Tests in Oncology Market Report (Status and Outlook)

October 2018 | 118 pages | ID: 295889BFA01EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Companion Diagnostic Tests in Oncology market for 2018-2023.
Increasing incidence of cancer, rising cost burden of cancer treatment, and increasing mortalities due to cancer, are some of the major reasons for increasing demand for new and technologically advanced treatment options, therapies, and drugs for the treatment of cancer.

Over the next five years, LPI(LP Information) projects that Companion Diagnostic Tests in Oncology will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Companion Diagnostic Tests in Oncology market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Protein Detection
• DNA Detection

Segmentation by application:

• Pharmaceutical & Biotechnology Companies
• Medical Device Companies
• Research Institutes

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Abbott
• Roche
• Genomic Health
• QIAGEN
• Agilent
• Agendia
• BioMerieux
• Illumina
• Siemens Healthcare
• Thermo Fisher

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Companion Diagnostic Tests in Oncology market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Companion Diagnostic Tests in Oncology market by identifying its various subsegments.
• Focuses on the key global Companion Diagnostic Tests in Oncology players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Companion Diagnostic Tests in Oncology with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Companion Diagnostic Tests in Oncology submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL COMPANION DIAGNOSTIC TESTS IN ONCOLOGY MARKET REPORT (STATUS AND OUTLOOK)

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Companion Diagnostic Tests in Oncology Market Size 2013-2023
  2.1.2 Companion Diagnostic Tests in Oncology Market Size CAGR by Region
2.2 Companion Diagnostic Tests in Oncology Segment by Type
  2.2.1 Protein Detection
  2.2.2 DNA Detection
2.3 Companion Diagnostic Tests in Oncology Market Size by Type
  2.3.1 Global Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2013-2018)
  2.3.2 Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type (2013-2018)
2.4 Companion Diagnostic Tests in Oncology Segment by Application
  2.4.1 Pharmaceutical & Biotechnology Companies
  2.4.2 Medical Device Companies
  2.4.3 Research Institutes
2.5 Companion Diagnostic Tests in Oncology Market Size by Application
  2.5.1 Global Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2013-2018)
  2.5.2 Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Application (2013-2018)

3 GLOBAL COMPANION DIAGNOSTIC TESTS IN ONCOLOGY BY PLAYERS

3.1 Global Companion Diagnostic Tests in Oncology Market Size Market Share by Players
  3.1.1 Global Companion Diagnostic Tests in Oncology Market Size by Players (2016-2018)
  3.1.2 Global Companion Diagnostic Tests in Oncology Market Size Market Share by Players (2016-2018)
3.2 Global Companion Diagnostic Tests in Oncology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 COMPANION DIAGNOSTIC TESTS IN ONCOLOGY BY REGIONS

4.1 Companion Diagnostic Tests in Oncology Market Size by Regions
4.2 Americas Companion Diagnostic Tests in Oncology Market Size Growth
4.3 APAC Companion Diagnostic Tests in Oncology Market Size Growth
4.4 Europe Companion Diagnostic Tests in Oncology Market Size Growth
4.5 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Growth

5 AMERICAS

5.1 Americas Companion Diagnostic Tests in Oncology Market Size by Countries
5.2 Americas Companion Diagnostic Tests in Oncology Market Size by Type
5.3 Americas Companion Diagnostic Tests in Oncology Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Companion Diagnostic Tests in Oncology Market Size by Countries
6.2 APAC Companion Diagnostic Tests in Oncology Market Size by Type
6.3 APAC Companion Diagnostic Tests in Oncology Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Companion Diagnostic Tests in Oncology by Countries
7.2 Europe Companion Diagnostic Tests in Oncology Market Size by Type
7.3 Europe Companion Diagnostic Tests in Oncology Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Companion Diagnostic Tests in Oncology by Countries
8.2 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Type
8.3 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL COMPANION DIAGNOSTIC TESTS IN ONCOLOGY MARKET FORECAST

10.1 Global Companion Diagnostic Tests in Oncology Market Size Forecast (2018-2023)
10.2 Global Companion Diagnostic Tests in Oncology Forecast by Regions
  10.2.1 Global Companion Diagnostic Tests in Oncology Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Companion Diagnostic Tests in Oncology Forecast by Type
10.8 Global Companion Diagnostic Tests in Oncology Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Abbott
  11.1.1 Company Details
  11.1.2 Companion Diagnostic Tests in Oncology Product Offered
  11.1.3 Abbott Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Abbott News
11.2 Roche
  11.2.1 Company Details
  11.2.2 Companion Diagnostic Tests in Oncology Product Offered
  11.2.3 Roche Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Roche News
11.3 Genomic Health
  11.3.1 Company Details
  11.3.2 Companion Diagnostic Tests in Oncology Product Offered
  11.3.3 Genomic Health Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Genomic Health News
11.4 QIAGEN
  11.4.1 Company Details
  11.4.2 Companion Diagnostic Tests in Oncology Product Offered
  11.4.3 QIAGEN Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 QIAGEN News
11.5 Agilent
  11.5.1 Company Details
  11.5.2 Companion Diagnostic Tests in Oncology Product Offered
  11.5.3 Agilent Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Agilent News
11.6 Agendia
  11.6.1 Company Details
  11.6.2 Companion Diagnostic Tests in Oncology Product Offered
  11.6.3 Agendia Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Agendia News
11.7 BioMerieux
  11.7.1 Company Details
  11.7.2 Companion Diagnostic Tests in Oncology Product Offered
  11.7.3 BioMerieux Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 BioMerieux News
11.8 Illumina
  11.8.1 Company Details
  11.8.2 Companion Diagnostic Tests in Oncology Product Offered
  11.8.3 Illumina Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Illumina News
11.9 Siemens Healthcare
  11.9.1 Company Details
  11.9.2 Companion Diagnostic Tests in Oncology Product Offered
  11.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 Siemens Healthcare News
11.10 Thermo Fisher
  11.10.1 Company Details
  11.10.2 Companion Diagnostic Tests in Oncology Product Offered
  11.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2018)
  11.10.4 Main Business Overview
  11.10.5 Thermo Fisher News

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Companion Diagnostic Tests in Oncology
Figure Companion Diagnostic Tests in Oncology Report Years Considered
Figure Market Research Methodology
Figure Global Companion Diagnostic Tests in Oncology Market Size Growth Rate 2013-2023 ($ Millions)
Table Companion Diagnostic Tests in Oncology Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Protein Detection
Table Major Players of DNA Detection
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2013-2018)
Figure Global Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2013-2018)
Figure Global Protein Detection Market Size Growth Rate
Figure Global DNA Detection Market Size Growth Rate
Figure Companion Diagnostic Tests in Oncology Consumed in Pharmaceutical & Biotechnology Companies
Figure Global Companion Diagnostic Tests in Oncology Market: Pharmaceutical & Biotechnology Companies (2013-2018) ($ Millions)
Figure Global Pharmaceutical & Biotechnology Companies YoY Growth ($ Millions)
Figure Companion Diagnostic Tests in Oncology Consumed in Medical Device Companies
Figure Global Companion Diagnostic Tests in Oncology Market: Medical Device Companies (2013-2018) ($ Millions)
Figure Global Medical Device Companies YoY Growth ($ Millions)
Figure Companion Diagnostic Tests in Oncology Consumed in Research Institutes
Figure Global Companion Diagnostic Tests in Oncology Market: Research Institutes (2013-2018) ($ Millions)
Figure Global Research Institutes YoY Growth ($ Millions)
Table Global Companion Diagnostic Tests in Oncology Market Size by Application (2013-2018) ($ Millions)
Table Global Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2013-2018)
Figure Global Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2013-2018)
Figure Global Companion Diagnostic Tests in Oncology Market Size in Pharmaceutical & Biotechnology Companies Growth Rate
Figure Global Companion Diagnostic Tests in Oncology Market Size in Medical Device Companies Growth Rate
Figure Global Companion Diagnostic Tests in Oncology Market Size in Research Institutes Growth Rate
Table Global Companion Diagnostic Tests in Oncology Revenue by Players (2016-2018) ($ Millions)
Table Global Companion Diagnostic Tests in Oncology Revenue Market Share by Players (2016-2018)
Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share by Players in 2017
Table Global Companion Diagnostic Tests in Oncology Key Players Head office and Products Offered
Table Companion Diagnostic Tests in Oncology Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Companion Diagnostic Tests in Oncology Market Size by Regions 2013-2018 ($ Millions)
Table Global Companion Diagnostic Tests in Oncology Market Size Market Share by Regions 2013-2018
Figure Global Companion Diagnostic Tests in Oncology Market Size Market Share by Regions 2013-2018
Figure Americas Companion Diagnostic Tests in Oncology Market Size 2013-2018 ($ Millions)
Figure APAC Companion Diagnostic Tests in Oncology Market Size 2013-2018 ($ Millions)
Figure Europe Companion Diagnostic Tests in Oncology Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Companion Diagnostic Tests in Oncology Market Size 2013-2018 ($ Millions)
Table Americas Companion Diagnostic Tests in Oncology Market Size by Countries (2013-2018) ($ Millions)
Table Americas Companion Diagnostic Tests in Oncology Market Size Market Share by Countries (2013-2018)
Figure Americas Companion Diagnostic Tests in Oncology Market Size Market Share by Countries in 2017
Table Americas Companion Diagnostic Tests in Oncology Market Size by Type (2013-2018) ($ Millions)
Table Americas Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2013-2018)
Figure Americas Companion Diagnostic Tests in Oncology Market Size Market Share by Type in 2017
Table Americas Companion Diagnostic Tests in Oncology Market Size by Application (2013-2018) ($ Millions)
Table Americas Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2013-2018)
Figure Americas Companion Diagnostic Tests in Oncology Market Size Market Share by Application in 2017
Figure United States Companion Diagnostic Tests in Oncology Market Size Growth 2013-2018 ($ Millions)
Figure Canada Companion Diagnostic Tests in Oncology Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Companion Diagnostic Tests in Oncology Market Size Growth 2013-2018 ($ Millions)
Table APAC Companion Diagnostic Tests in Oncology Market Size by Countries (2013-2018) ($ Millions)
Table APAC Companion Diagnostic Tests in Oncology Market Size Market Share by Countries (2013-2018)
Figure APAC Companion Diagnostic Tests in Oncology Market Size Market Share by Countries in 2017
Table APAC Companion Diagnostic Tests in Oncology Market Size by Type (2013-2018) ($ Millions)
Table APAC Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2013-2018)
Figure APAC Companion Diagnostic Tests in Oncology Market Size Market Share by Type in 2017
Table APAC Companion Diagnostic Tests in Oncology Market Size by Application (2013-2018) ($ Millions)
Table APAC Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2013-2018)
Figure APAC Companion Diagnostic Tests in Oncology Market Size Market Share by Application in 2017
Figure China Companion Diagnostic Tests in Oncology Market Size Growth 2013-2018 ($ Millions)
Figure Japan Companion Diagnostic Tests in Oncology Market Size Growth 2013-2018 ($ Millions)
Figure Korea Companion Diagnostic Tests in Oncology Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Companion Diagnostic Tests in Oncology Market Size Growth 2013-2018 ($ Millions)
Figure India Companion Diagnostic Tests in Oncology Market Size Growth 2013-2018 ($ Millions)
Figure Australia Companion Diagnostic Tests in Oncology Market Size Growth 2013-2018 ($ Millions)
Table Europe Companion Diagnostic Tests in Oncology Market Size by Countries (2013-2018) ($ Millions)
Table Europe Companion Diagnostic Tests in Oncology Market Size Market Share by Countries (2013-2018)
Figure Europe Companion Diagnostic Tests in Oncology Market Size Market Share by Countries in 2017
Table Europe Companion Diagnostic Tests in Oncology Market Size by Type (2013-2018) ($ Millions)
Table Europe Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2013-2018)
Figure Europe Companion Diagnostic Tests in Oncology Market Size Market Share by Type in 2017
Table Europe Companion Diagnostic Tests in Oncology Market Size by Application (2013-2018) ($ Millions)
Table Europe Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2013-2018)
Figure Europe Companion Diagnostic Tests in Oncology Market Size Market Share by Application in 2017
Figure Germany Companion Diagnostic Tests in Oncology Market Size Growth 2013-2018 ($ Millions)
Figure France Companion Diagnostic Tests in Oncology Market Size Growth 2013-2018 ($ Millions)
Figure UK Companion Diagnostic Tests in Oncology Market Size Growth 2013-2018 ($ Millions)
Figure Italy Companion Diagnostic Tests in Oncology Market Size Growth 2013-2018 ($ Millions)
Figure Russia Companion Diagnostic Tests in Oncology Market Size Growth 2013-2018 ($ Millions)
Figure Spain Companion Diagnostic Tests in Oncology Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Market Share by Countries in 2017
Table Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Market Share by Type in 2017
Table Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Market Share by Application in 2017
Figure Egypt Companion Diagnostic Tests in Oncology Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Companion Diagnostic Tests in Oncology Market Size Growth 2013-2018 ($ Millions)
Figure Israel Companion Diagnostic Tests in Oncology Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Companion Diagnostic Tests in Oncology Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Companion Diagnostic Tests in Oncology Market Size Growth 2013-2018 ($ Millions)
Figure Global Companion Diagnostic Tests in Oncology arket Size Forecast (2018-2023) ($ Millions)
Table Global Companion Diagnostic Tests in Oncology Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Companion Diagnostic Tests in Oncology Market Size Market Share Forecast by Regions
Figure Americas Companion Diagnostic Tests in Oncology Market Size 2018-2023 ($ Millions)
Figure APAC Companion Diagnostic Tests in Oncology Market Size 2018-2023 ($ Millions)
Figure Europe Companion Diagnostic Tests in Oncology Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Companion Diagnostic Tests in Oncology Market Size 2018-2023 ($ Millions)
Figure United States Companion Diagnostic Tests in Oncology Market Size 2018-2023 ($ Millions)
Figure Canada Companion Diagnostic Tests in Oncology Market Size 2018-2023 ($ Millions)
Figure Mexico Companion Diagnostic Tests in Oncology Market Size 2018-2023 ($ Millions)
Figure Brazil Companion Diagnostic Tests in Oncology Market Size 2018-2023 ($ Millions)
Figure China Companion Diagnostic Tests in Oncology Market Size 2018-2023 ($ Millions)
Figure Japan Companion Diagnostic Tests in Oncology Market Size 2018-2023 ($ Millions)
Figure Korea Companion Diagnostic Tests in Oncology Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Companion Diagnostic Tests in Oncology Market Size 2018-2023 ($ Millions)
Figure India Companion Diagnostic Tests in Oncology Market Size 2018-2023 ($ Millions)
Figure Australia Companion Diagnostic Tests in Oncology Market Size 2018-2023 ($ Millions)
Figure Germany Companion Diagnostic Tests in Oncology Market Size 2018-2023 ($ Millions)
Figure France Companion Diagnostic Tests in Oncology Market Size 2018-2023 ($ Millions)
Figure UK Companion Diagnostic Tests in Oncology Market Size 2018-2023 ($ Millions)
Figure Italy Companion Diagnostic Tests in Oncology Market Size 2018-2023 ($ Millions)
Figure Russia Companion Diagnostic Tests in Oncology Market Size 2018-2023 ($ Millions)
Figure Spain Companion Diagnostic Tests in Oncology Market Size 2018-2023 ($ Millions)
Figure Egypt Companion Diagnostic Tests in Oncology Market Size 2018-2023 ($ Millions)
Figure South Africa Companion Diagnostic Tests in Oncology Market Size 2018-2023 ($ Millions)
Figure Israel Companion Diagnostic Tests in Oncology Market Size 2018-2023 ($ Millions)
Figure Turkey Companion Diagnostic Tests in Oncology Market Size 2018-2023 ($ Millions)
Figure GCC Countries Companion Diagnostic Tests in Oncology Market Size 2018-2023 ($ Millions)
Table Global Companion Diagnostic Tests in Oncology Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Companion Diagnostic Tests in Oncology Market Size Market Share Forecast by Type (2018-2023)
Table Global Companion Diagnostic Tests in Oncology Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Companion Diagnostic Tests in Oncology Market Size Market Share Forecast by Application (2018-2023)
Table Abbott Basic Information, Head Office, Major Market Areas and Its Competitors
Table Abbott Companion Diagnostic Tests in Oncology Revenue and Gross Margin (2016-2018)
Figure Abbott Companion Diagnostic Tests in Oncology Market Share (2016-2018)
Table Roche Basic Information, Head Office, Major Market Areas and Its Competitors
Table Roche Companion Diagnostic Tests in Oncology Revenue and Gross Margin (2016-2018)
Figure Roche Companion Diagnostic Tests in Oncology Market Share (2016-2018)
Table Genomic Health Basic Information, Head Office, Major Market Areas and Its Competitors
Table Genomic Health Companion Diagnostic Tests in Oncology Revenue and Gross Margin (2016-2018)
Figure Genomic Health Companion Diagnostic Tests in Oncology Market Share (2016-2018)
Table QIAGEN Basic Information, Head Office, Major Market Areas and Its Competitors
Table QIAGEN Companion Diagnostic Tests in Oncology Revenue and Gross Margin (2016-2018)
Figure QIAGEN Companion Diagnostic Tests in Oncology Market Share (2016-2018)
Table Agilent Basic Information, Head Office, Major Market Areas and Its Competitors
Table Agilent Companion Diagnostic Tests in Oncology Revenue and Gross Margin (2016-2018)
Figure Agilent Companion Diagnostic Tests in Oncology Market Share (2016-2018)
Table Agendia Basic Information, Head Office, Major Market Areas and Its Competitors
Table Agendia Companion Diagnostic Tests in Oncology Revenue and Gross Margin (2016-2018)
Figure Agendia Companion Diagnostic Tests in Oncology Market Share (2016-2018)
Table BioMerieux Basic Information, Head Office, Major Market Areas and Its Competitors
Table BioMerieux Companion Diagnostic Tests in Oncology Revenue and Gross Margin (2016-2018)
Figure BioMerieux Companion Diagnostic Tests in Oncology Market Share (2016-2018)
Table Illumina Basic Information, Head Office, Major Market Areas and Its Competitors
Table Illumina Companion Diagnostic Tests in Oncology Revenue and Gross Margin (2016-2018)
Figure Illumina Companion Diagnostic Tests in Oncology Market Share (2016-2018)
Table Siemens Healthcare Basic Information, Head Office, Major Market Areas and Its Competitors
Table Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue and Gross Margin (2016-2018)
Figure Siemens Healthcare Companion Diagnostic Tests in Oncology Market Share (2016-2018)
Table Thermo Fisher Basic Information, Head Office, Major Market Areas and Its Competitors
Table Thermo Fisher Companion Diagnostic Tests in Oncology Revenue and Gross Margin (2016-2018)
Figure Thermo Fisher Companion Diagnostic Tests in Oncology Market Share (2016-2018)